NVS (Novartis AG) Prakiraan wutah bathi resik saben saham ing taun iki

NVS (Novartis AG) - tandha merek perusahaan

The complexity of gene therapy technological chains creates risks of healthcare dependence on the infrastructure of Novartis AG (NVS). The history of annual net income per share growth confirms the business's resilience, where -0.80 captures the current state of the parameter. Stability is guaranteed by inelastic demand for expensive rare disease treatments and robust patent protection against generic competition.

NVS - Wutah bathi ing taun lumaku Novartis ing rentang 04.07.2022 - 15.11.2026

Rincian analitis lan laporan data perusahaan Novartis Pharma (NVS)

- kuotasi lan prakiraan analis:
Kurs saham Novartis Inc.|NVS - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Novartis AG|NVS - Nilai Total Perusahaan
- data nilai buku modal saham:
Ekuitas saben Saham Novartis|NVS - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas novartis.com|NVS - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Rasio Utang marang Ekuitas Novartis AG|NVS - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Novartis Inc.|NVS - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Novartis|NVS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Novartis|Rasio jangkoan perantara novartis.com
- statistik bathi lan rasio pasar:
NVS - Penghasilan resik|Bathi resik mangsa ngarep Novartis AG|NVS - Pangali P/E|Kapitalisasi marang proyeksi bathi novartis.com|NVS - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Novartis Corporation|NVS - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Novartis|NVS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan novartis.com|NVS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Novartis AG
- informasi babagan volume dodolan lan pendapatan:
NVS - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Novartis AG|NVS - Kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan Novartis AG
Ringkesan analisis perusahaan:Novartis Inc., NVS
Produk merek Novartis Inc.

This indicator measures the year-over-year dynamics of net income per share, allowing investors to filter out market noise and assess the real efficiency of capital generation. By analyzing the growth rate of net income per share compared to the previous year, an investor can see how the scientific potential and restructuring of Novartis AG (NVS) translate into financial results, confirming the fundamental stability of this pharmaceutical leader.

Pesaing langsung

Wutah bathi saben saham ing taun iki LLY|ABBV (AbbVie) - Wutah bathi ing taun lumaku|astrazeneca.com (AZN) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Merck Sharp & Dohme (MRK)|Novo Nordisk - Wutah bathi saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Amgen Inc. AMGN|Owah-owahan bathi resik saben saham ing taun lumaku Pfizer Corp|SNY - Wutah bathi saben saham ing taun lumaku|BMY: Wutah bathi saben saham ing taun lumaku|GSK plc (GSK) - Wutah bathi saben saham ing taun lumaku|Takeda Pharmaceutical Company (TAK) - Wutah bathi ing taun lumaku|TEVA (tevapharm.com) - Wutah bathi ing taun lumaku|Dr. Reddy's Laboratories (RDY) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku VTRS|Prakiraan wutah bathi resik saben saham ing taun iki Roivant Sciences|Zai Lab - Wutah bathi resik saben saham ing taun iki|BHC - Wutah bathi resik saben saham ing taun iki|COSM - Wutah bathi saben saham ing taun lumaku